Ignite Creation Date:
2025-12-26 @ 11:12 AM
Ignite Modification Date:
2026-04-23 @ 4:48 AM
Study NCT ID:
NCT02998528
Status:
COMPLETED
Last Update Posted:
2025-01-24
First Post:
2016-12-16
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Neoadjuvant Study of Nivolumab Plus Ipilimumab or Nivolumab Plus Chemotherapy Versus Chemotherapy Alone in Early Stage Non-Small Cell Lung Cancer (NSCLC)
Sponsor:
Bristol-Myers Squibb
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-03-04
Start Date Type:
ACTUAL
Primary Completion Date:
2021-09-08
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-12-06
Completion Date Type:
ACTUAL
First Submit Date:
2016-12-16
First Submit QC Date:
None
Study First Post Date:
2016-12-20
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2022-08-31
Results First Submit QC Date:
None
Results First Post Date:
2022-09-28
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-01-13
Last Update Post Date:
2025-01-24
Last Update Post Date Type:
ACTUAL